MetLife Investment Management, LLC - OCULAR THERAPEUTIX INC ownership

Back to all holdings Add to watchlist

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 68 filers reported holding OCULAR THERAPEUTIX INC in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 1.1%.

Links
Filings
External links
Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$127,635
-39.1%
40,6480.0%0.00%
-50.0%
Q2 2023$209,744
-2.1%
40,6480.0%0.00%0.0%
Q1 2023$214,215
+183.7%
40,648
+51.3%
0.00%
+100.0%
Q4 2022$75,508
-55.5%
26,871
-34.3%
0.00%0.0%
Q3 2022$169,660
+3.2%
40,8820.0%0.00%0.0%
Q2 2022$164,346
+44.9%
40,882
+78.4%
0.00%0.0%
Q1 2022$113,424
-42.7%
22,914
-19.3%
0.00%
-50.0%
Q4 2021$197,983
-1.9%
28,405
+40.7%
0.00%0.0%
Q3 2021$201,820
-49.4%
20,182
-28.3%
0.00%
-50.0%
Q2 2021$399,011
-13.6%
28,1390.0%0.00%0.0%
Q1 2021$461,761
-21.1%
28,139
-0.4%
0.00%
-33.3%
Q4 2020$585,106
+180.8%
28,266
+3.2%
0.01%
+200.0%
Q3 2020$208,392
+19.2%
27,384
+30.5%
0.00%0.0%
Q2 2020$174,838
+68.3%
20,9890.0%0.00%
+100.0%
Q1 2020$103,896
-11.2%
20,989
+20.9%
0.00%0.0%
Q2 2018$117,000–17,358–0.00%–
 Download
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2018
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders